StARLITe provides unique, up-to date, highly curated target-compound SAR relationships; electronically indexed to allow fully flexible data mining strategies. 

With its ~300,000 chemically tractable compounds and ~5,000 curated targets, the StARLITe database is a high value addition to the historical screening files of the largest pharmaceutical companies.  A fully scalable drug discovery tool, StARLITe can provide a large-scale project overview down to micro/detailed views of compound activities.

StARLITe is essential for both chemists and biologists

Chemists: Unique cheminformatics resource, searchable by compound structure and sub-structure

• Efficiently identify chemistry program starting points

• Predict alternative targets for compounds

• Identify chemical scaffold hopping opportunities

• Perform compound potency profiling

Biologists: Links seamlessly to chemistry, searchable by sequence and text

• Identify which compounds have been screened against a given target

• Rapid access to chemical target validation tools

• Target protein family library design

• Identify target selectivity issues

Integration
StARLITe is supplied as an Oracle 9i database (or as exported flat files from an Oracle database), it can be readily integrated into your current system and readily integrates with our SARfari and DrugStore systems.

Accessing StARLITe
StARLITe is available under license from BioFocus DPI as a stand alone product or as part of a collaborative program.

For more information, download the StARLITe factsheet or contact us.

DrugStore™, StARLITe™ and SARfari™ are trademarks of Galapagos NV and/or its affiliates.